Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International

Wikipedia Affiliate Button

Home > Press > How to keep boron inside cells during radiotherapy: a simple novel approach to cancer treatment

Abstract:
Boron neutron capture therapy (BNCT) is a technique in which p-boronophenylalanine (BPA) is transferred to cancer cells, and the boron in it undergoes nuclear fission reaction upon irradiation of thermal neutrons, releasing high energy particles that kill the cells. However, current technology allows only a short timeframe of BPA in the cell. Scientists at Tokyo Institute of Technology (Tokyo Tech), Kyoto University, and Innovation Center of NanoMedicine (iCONM) improved upon current BNCT by combining BPA with poly(vinyl alcohol) to produce the PVA-BPA complex, which has a longer cell retention time, enhancing the cancer-killing potential of BNCT.

How to keep boron inside cells during radiotherapy: a simple novel approach to cancer treatment

Tokyo, Japan | Posted on January 24th, 2020

The growing knowledge about cancer biology has enhanced the development of many therapeutic strategies that involve selective targeting and killing of cancer cells. One such therapeutic option is boron neutron capture therapy (BNCT), a radiotherapy process involving transferring boron into cancer cells, and exposing it to neutron particles, causing it to undergo nuclear fission, which kills the cancer cells. If we can ensure that boron is present only in cancer cells, we can specifically destroy only cancer cells, without harming the normal cells of the body.

Scientists first discovered the way to induce this "selective uptake" using p-boronophenylalanine (BPA). BPA is a boron-containing compound with a phenylalanine structure. One of the factors that distinguishes cancer cells from normal cells is an overabundance of special structures called "LAT1 amino acid transporters", which recognize and allow the transport of phenylalanine into the cell. So, when BPA is present outside cancer cells, these transporters on the cell-surface allow it to enter cancer cells, permitting successful BNCT. BPA has long been considered the best drug available for BNCT.

However, BPA has a drawback; once BPA levels increase within the cancer cells, it is expelled back out via an "antiport" mechanism, making it challenging for BNCT to be effective in some cases. Thus, patients are required to receive a continuous infusion of BPA for 3060 minutes, to maintain the necessary amount in the cells for the reaction to be successful. This also leaves the door open for human errors, such as the possibility of dislodging the needle during the process.

To overcome these drawbacks, scientists at Tokyo Tech, Kyoto University and iCONM led by Prof. Nobuhiro Nishiyama decided to explore other means of retaining boron inside cancer cells for longer periods. "We assumed," Prof. Nishiyama states, "that modulating the presence of BPA inside the cell will ensure that they are not sent back out via their antiport mechanism."

To examine this, they mixed a compound called poly(vinyl alcohol) (PVA) and BPA together, to form a PVA-BPA complex, and observed the internalization of this compound in cancer cells. They found that the addition of PVA did not affect the phenylalanine structure of BPA, allowing the LAT1 transporters to recognize the PVA-BPA complex. However, as this complex was too large to pass through the transporters, the LAT1 transporters instead engulfed the complex in organelles called endosomes and transported them into the cells. Since BPA was now safely located in endosomes, the cancer cell was not able to push it out immediately by the antiport mechanism. This ensured that boron remains in cells for a long enough time for the cancer cells to be effectively killed. This method was also tested in animal models, and anti-cancer activities of BNCT were found to be enhanced.

Addition of PVA thus presents an extremely simple solution to boost the therapeutic potential of BPA. "This technique is effortless," notes Prof. Nishiyama, "and offers a novel approach for drug delivery, focusing on the metabolic elimination processes of drugs. We will advance research on the PVA-BPA complex for clinical trials in cooperation with STELLA PHARMA CORPORATION who has conducted BPA clinical trials."

####

For more information, please click here

Contacts:
Assistant Professor Takahiro Nomoto

Institute of Innovative Research,,
Tokyo Institute of Technology

Tel +81-45-924 -5226

Professor Nobuhiro Nishiyama

Institute of Innovative Research,,
Tokyo Institute of Technology


Tel +81-45-924 -5240

Contact

Public Relations Section, Tokyo Institute of Technology


Tel +81-3-5734-2975

Copyright © Tokyo Institute of Technology

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related Links

Reference

Related News Press

News and information

Researchers show what drives a novel, ordered assembly of alternating peptides February 20th, 2020

CEA-Leti and CEA-IRIG Demonstrate Quantum Integrated Circuit Combining Quantum Dot with Digital-Analog Circuits on CMOS Chip: Presentation at ISSCC 2020 Shows Role FD-SOI Can Play in Embedding Qubit Arrays with Classic Electronics to Build Large-Scale Quantum Silicon Processors February 20th, 2020

CEA-Leti Presents High-Performance Processor Breakthrough With Active Interposer and 3D Stacked Chiplets at ISSCC 2020 February 19th, 2020

New green technology from UMass Amherst generates electricity 'out of thin air' Renewable device could help mitigate climate change, power medical devices February 17th, 2020

Cancer

Let the europium shine brighter January 21st, 2020

Copper-based nanomaterials can kill cancer cells in mice January 10th, 2020

Tech company NANOBIOTIX announces late-stage registration trial and global development plan for 2020 January 8th, 2020

International Conference and Exhibition on Nanotechnology - Nano Seoul 2020 January 3rd, 2020

Possible Futures

Researchers show what drives a novel, ordered assembly of alternating peptides February 20th, 2020

CEA-Leti and CEA-IRIG Demonstrate Quantum Integrated Circuit Combining Quantum Dot with Digital-Analog Circuits on CMOS Chip: Presentation at ISSCC 2020 Shows Role FD-SOI Can Play in Embedding Qubit Arrays with Classic Electronics to Build Large-Scale Quantum Silicon Processors February 20th, 2020

CEA-Leti Presents High-Performance Processor Breakthrough With Active Interposer and 3D Stacked Chiplets at ISSCC 2020 February 19th, 2020

New green technology from UMass Amherst generates electricity 'out of thin air' Renewable device could help mitigate climate change, power medical devices February 17th, 2020

Nanomedicine

Novel formulation permits use of toxin from rattlesnake venom to treat chronic pain: Researchers Butantan Institute succeeded in reducing the toxicity and potentiating the analgesic effect of crotoxin by encapsulating it in nanostructured silica -- the results of tests in an anim February 14th, 2020

Gold nanoclusters: new frontier for developing medication for treatment of Alzheimer's disease February 14th, 2020

Nanotech company granted FDA Fast Track for treatment of head & neck cancer February 10th, 2020

Arrowhead Reports Interim Clinical Data on Cardiometabolic Candidates ARO-APOC3 and ARO-ANG3 February 5th, 2020

Announcements

CEA-Leti and CEA-IRIG Demonstrate Quantum Integrated Circuit Combining Quantum Dot with Digital-Analog Circuits on CMOS Chip: Presentation at ISSCC 2020 Shows Role FD-SOI Can Play in Embedding Qubit Arrays with Classic Electronics to Build Large-Scale Quantum Silicon Processors February 20th, 2020

CEA-Leti Presents High-Performance Processor Breakthrough With Active Interposer and 3D Stacked Chiplets at ISSCC 2020 February 19th, 2020

New green technology from UMass Amherst generates electricity 'out of thin air' Renewable device could help mitigate climate change, power medical devices February 17th, 2020

KIST unveils the mystery of van der Waals magnets, a material for future semiconductors: Overcoming the limits of current magnetic materials, giving hope for development of next-generation semiconductors February 14th, 2020

Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers/Posters

Researchers show what drives a novel, ordered assembly of alternating peptides February 20th, 2020

New green technology from UMass Amherst generates electricity 'out of thin air' Renewable device could help mitigate climate change, power medical devices February 17th, 2020

Does graphene cause or prevent the corrosion of copper? New study finally settles the debate: Scientists in Korea are first to observe an unprecedented way in which graphene forms a hybrid layer that prevents copper corrosion February 14th, 2020

KIST unveils the mystery of van der Waals magnets, a material for future semiconductors: Overcoming the limits of current magnetic materials, giving hope for development of next-generation semiconductors February 14th, 2020

Nanobiotechnology

Novel formulation permits use of toxin from rattlesnake venom to treat chronic pain: Researchers Butantan Institute succeeded in reducing the toxicity and potentiating the analgesic effect of crotoxin by encapsulating it in nanostructured silica -- the results of tests in an anim February 14th, 2020

Gold nanoclusters: new frontier for developing medication for treatment of Alzheimer's disease February 14th, 2020

Nanotech company granted FDA Fast Track for treatment of head & neck cancer February 10th, 2020

Arrowhead Reports Interim Clinical Data on Cardiometabolic Candidates ARO-APOC3 and ARO-ANG3 February 5th, 2020

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project